Patent · US Active

Biphenyl derivatives useful as glucagon receptor antagonists

US9045389B2 · kind B2 · utility

0Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2012
Grant dateJun 2, 2015
Priority date
Expiry dateJun 7, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to biphenyl derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.